Healthpeak Properties, Inc.
DOC- Exchange
- NYSE
- Industry
- Real Estate Investment Trusts
- SEC CIK
- 0000765880
In the last 90 days, Healthpeak Properties, Inc. insiders filed 0 open-market purchases and 1 sale; 768 institutions reported holding it in 13F filings for Q2 2026, worth $14.1B in total; no superinvestor holds it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Nov 5, 2026, 12:06 AM ET
Revenue flow, FY2025
Where the revenue went in FY2025, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 2, 2026 | Feb 3, 2025 | Feb 8, 2024 | Feb 7, 2023 | Feb 8, 2022 |
| Revenue | $2.82B | $2.70B | $2.18B | $2.06B | $1.90B |
| Cost of revenue | – | $1.07B | $902.1M | $863.0M | $773.3M |
| Operating expenses | – | – | $902.1M | $863.0M | $773.3M |
| Selling, general and administrative | $90.4M | $97.2M | $95.1M | $131.0M | $98.3M |
| Interest expense | $305.2M | $280.4M | $200.3M | $172.9M | $158.0M |
| Income tax | $9.28M | $4.35M | -$9.62M | -$4.42M | -$3.26M |
| Net income | $71.3M | $243.1M | $306.0M | $500.4M | $505.5M |
| EPS, basic | $0.10 | $0.36 | $0.56 | $0.92 | $0.93 |
| EPS, diluted | $0.10 | $0.36 | $0.56 | $0.92 | $0.93 |
| Weighted shares, basic | 696.0M | 675.7M | 547.0M | 538.8M | 538.9M |
| Weighted shares, diluted | 696.0M | 676.2M | 547.3M | 539.1M | 539.2M |
| Margins and growth | |||||
| Net margin | 2.5% | 9.0% | 14.0% | 24.3% | 26.7% |
| Revenue growth, year over year | +4.5% | +23.8% | +5.8% | +8.7% | +15.3% |
| Net income growth, year over year | −70.7% | −20.5% | −38.9% | −1.0% | +22.2% |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 2, 2026 | Feb 3, 2025 | Feb 8, 2024 | Feb 7, 2023 | Feb 8, 2022 |
| Cash and equivalents | $467.5M | $119.8M | $117.6M | $72.0M | $158.3M |
| Goodwill | $68.5M | $68.5M | $18.0M | $18.0M | $18.0M |
| Intangible assets | $654.5M | $817.3M | $314.2M | $418.1M | $519.8M |
| Total assets | $20.3B | $19.9B | $15.7B | $15.8B | $15.3B |
| Long-term debt | $9.85B | $8.72B | $6.88B | $6.50B | $6.17B |
| Total liabilities | $12.0B | $10.9B | $8.77B | $8.48B | $8.11B |
| Shareholders' equity | $8.14B | $9.06B | $6.88B | $7.18B | $7.06B |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 2, 2026 | Feb 3, 2025 | Feb 8, 2024 | Feb 7, 2023 | Feb 8, 2022 |
| Operating cash flow | $1.25B | $1.07B | $956.2M | $900.3M | $795.2M |
| Capital expenditures | $894.9M | $736.8M | $774.6M | $962.0M | $759.7M |
| Free cash flow | $357.0M | $333.7M | $181.7M | -$61.7M | $35.5M |
| Depreciation and amortization | $1.06B | $1.06B | $749.9M | $710.6M | $684.3M |
| Stock-based compensation | $14.4M | $15.5M | $14.5M | $26.5M | $18.2M |
| Dividends paid | $849.1M | $794.8M | $657.0M | $648.0M | $650.1M |
| Share buybacks | $97.1M | $190.7M | $6.52M | $67.8M | $12.8M |
| Investing cash flow | -$1.03B | -$113.8M | -$576.8M | -$876.3M | $531.0M |
| Financing cash flow | $136.1M | -$941.4M | -$337.3M | -$116.5M | -$1.29B |
| Net change in cash | $353.4M | $15.3M | $42.2M | -$92.6M | $37.8M |
| Ratio | |||||
| Stock-based compensation, % of revenue | 0.5% | 0.6% | 0.7% | 1.3% | 1.0% |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
| Cover date | Shares outstanding | Change in a year | Filing |
|---|---|---|---|
| Oct 30, 2026 | 689.5M | −0.8% | SEC |
| Aug 3, 2026 | 689.5M | −0.8% | SEC |
| May 4, 2026 | 689.4M | −0.8% | SEC |
| Jan 30, 2026 | 695.0M | −0.6% | SEC |
| Oct 22, 2025 | 694.9M | −0.6% | SEC |
| Jul 23, 2025 | 694.9M | −0.6% | SEC |
| Apr 23, 2025 | 694.7M | −1.3% | SEC |
| Jan 31, 2025 | 699.6M | +27.9% | SEC |
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.